financetom
Business
financetom
/
Business
/
Foxconn's February revenue down 12.33% y/y, sees Q1 fall
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Foxconn's February revenue down 12.33% y/y, sees Q1 fall
Mar 5, 2024 12:06 AM

TAIPEI (Reuters) - Taiwan's Foxconn, the world's largest contract electronics maker and Apple's biggest iPhone assembler, reported on Tuesday February revenue fell 12.33% year-on-year, and predicted first-quarter outlook will decrease year-on-year.

Foxconn will report fourth quarter earnings on March 14, when it will also update its outlook.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
KULR Technology Stock Is Soaring Monday: What's Going On?
KULR Technology Stock Is Soaring Monday: What's Going On?
Nov 25, 2024
KULR Technology Group Inc ( KULR ) shares are trading higher Monday after the company announced it won a U.S. Navy contract for enhanced battery safety initiatives. What Happened: KULR Technology ( KULR ) was awarded a contract by the U.S. Navy to advance its Internal Short Circuit (ISC) technology to activate at higher temperatures. The development will support a wide...
Chewy Fiscal Q3 Results Expected to Show Momentum Across Business, Morgan Stanley Says
Chewy Fiscal Q3 Results Expected to Show Momentum Across Business, Morgan Stanley Says
Nov 25, 2024
12:10 PM EST, 11/25/2024 (MT Newswires) -- Chewy's (CHWY) fiscal Q3 results are likely to show continued momentum across the business, Morgan Stanley said in an earnings preview Monday. The online pet store is scheduled to report fiscal Q3 results on Dec. 4. Morgan Stanley projects revenue at roughly $2.86 billion. We expect [Chewy's Q3] print to show sustained momentum,...
Update: BridgeBio Pharma Shares Surge After Obtaining FDA Approval for Attruby
Update: BridgeBio Pharma Shares Surge After Obtaining FDA Approval for Attruby
Nov 25, 2024
12:09 PM EST, 11/25/2024 (MT Newswires) -- (Updates with stock price movement in the headline and first paragraph.) BridgeBio Pharma ( BBIO ) shares surged 20% Monday after the company said late Friday that the US Food and Drug Administration approved Attruby, a transthyretin stabilizer for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis in adults to...
Update: Market Chatter: Tesla Settles Lawsuit Against Rivian
Update: Market Chatter: Tesla Settles Lawsuit Against Rivian
Nov 25, 2024
12:06 PM EST, 11/25/2024 (MT Newswires) -- (Updates to include change in Rivian's stock price in the last paragraph.) Tesla has reached a conditional settlement in its 2020 lawsuit against Rivian Automotive ( RIVN ) over allegations of stealing employees and trade secrets, Bloomberg reported Saturday, citing a court filing. Tesla did not disclose details about the settlement in a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved